Form 8-K - Current report:
SEC Accession No. 0001104659-25-054976
Filing Date
2025-05-30
Accepted
2025-05-30 17:06:04
Documents
13
Period of Report
2025-05-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516553d1_8k.htm   iXBRL 8-K 27101
5 GRAPHIC tm2516553d1_8kimg001.jpg GRAPHIC 16103
  Complete submission text file 0001104659-25-054976.txt   237492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtva-20250529.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtva-20250529_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtva-20250529_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2516553d1_8k_htm.xml XML 3673
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 251012053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)